Francesca Fagiani - Concepedia

Author

Francesca Fagiani

University of Pavia ORCID

Also Known As

F Fagiani, F. Fagiani, Francesca Fagiani

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Pavia Istituto Universitario di Studi Superiori di Pavia University of Bologna Johns Hopkins University Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

About

Francesca Fagiani is an author at University of Pavia specializing in medicine, neuroprotection, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	164
2	Cell Biology	2	2	110
3	Allergy	1	1	68
4	Biochemistry	1	1	54
5	Neurology	1	1	54

Francesca Fagiani

Publications

549

Citations

H-Index

Page 1

	Year	Citations
PMI: A ΔΨm Independent Pharmacological Regulator of Mitophagy Daniel A. East, Francesca Fagiani, James Crosby, Chemistry & Biology	2014	147
Gene–Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres Sergio Modafferi, Xiali Zhong, André Kleensang, Environmental Health Perspectives	2021	81
Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids Melania Maria Serafini, Michele Catanzaro, Francesca Fagiani, Frontiers in Pharmacology Chemoprevention StrategyLipid PeroxidationCell DeathGarlic-derived HybridsRedox Biology	2020	68
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease Michela Rosini, Elena Simoni, Roberta Caporaso, European Journal of Medicinal Chemistry Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryAmyloid-β PeptideNeuropharmacology	2019	54
Targeting dementias through cancer kinases inhibition Francesca Fagiani, Cristina Lanni, Marco Racchi, Alzheimer s & Dementia Translational Research & Clinical Interventions ApoptosisCell DeathNeurochemical BiomarkersCancer Kinases InhibitionCancer Biology	2020	42
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression Mirco Masi, Enrico Garattini, Marco Bolis, Oncogenesis	2020	38
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis Francesca Fagiani, Edoardo Pedrini, Stefano Taverna, Cell Reports Medicine	2024	26
Dual-Functioning Scaffolds for the Treatment of Spinal Cord Injury: Alginate Nanofibers Loaded with the Sigma 1 Receptor (S1R) Agonist RC-33 in Chitosan Films Barbara Vigani, Silvia Rossi, Giuseppina Sandri, Marine Drugs	2019	24
A Composite Nanosystem as a Potential Tool for the Local Treatment of Glioblastoma: Chitosan-Coated Solid Lipid Nanoparticles Embedded in Electrospun Nanofibers Barbara Vigani, Caterina Valentino, Giuseppina Sandri, Polymers	2021	22
Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds Francesca Fagiani, Michele Catanzaro, Erica Buoso, Frontiers in Pharmacology	2020	18

Page 1